You are here: Industry Insights > Sabril

News List

Teva Announces U.S. Launch of a Generic Version of Sabril americanpharmaceuticalreview
February 14, 2019
Teva Pharmaceutical announced the launch of a generic version of Sabril (vigabatrin) tablets, 500 mg in the US, the first generic version of Sabril tablets to enter the US market.....
Generic version of seizure drug Sabril gets FDA approval europeanpharmaceuticalreview
January 21, 2019
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA…
FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy firstwordpharma
January 17, 2019
The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 1
FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy firstwordpharma
January 17, 2019
The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 1
FDA Approves First Generic Version of Sabril americanpharmaceuticalreview
January 17, 2019
The U.S. Food and Drug Administration (FDA) has approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures.....